With the planet’s forests facing numerous threats, advanced monitoring techniques are essential to preserve these crucial ...

Joey Wagner of BluePrint Supply Chain explains why it's critical to have a reliable quality assurance program and consistent ...

Learn more about data risk in solar energy development in PV Tech's webinar with PVCase, next Wednesday 13th November at 4 pm ...

Immunocore reports third quarter financial results and provides a business updateKIMMTRAK® (tebentafusp-tebn) net revenues of $80.2 million in 3Q ...

But after gaining more than 20 pounds during undergraduate and graduate school and feeling unhappy with her weight, the ...

In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

Drs Pavan Brahmbhatt and Amit Agarwal discuss best practices for managing amyloid-related imaging abnormalities in patients ...

Prescriptions of this GLP-1 class of diabetes and weight-loss medications ... monitor trade-offs between pharmacologic and ...

Chronic active antibody-mediated rejection (caAMR) is a common cause of allograft loss after transplantation, with no approved therapies. Clazakizumab, a monoclonal antibody that targets the ...

Weight management medications are transforming the landscape of obesity treatment, with semaglutide emerging as a ...

Officials reported the Berlin brushfire on Lamentation Mountain is contained Monday though they continue to suppress further ...

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of the ...